// App-Quantinova.ai

4209 : Targeting GPNMB with 89Zr-CR011 for PET imaging of triple negative breast cancer

Researchers

Presenter

  • Bernadette V. Marquez

Principal Investigators

  • Supum Lee

  • Tibor Keler

  • Thomas Hawthorne

  • Jeremy Hoog

  • Shunqiang Li

  • Cynthia Ma

  • Suzanne E. Lapi

Medical Centers

  • Washington University School of Medicine, St. Louis, MO

  • Celldex Therapeutics, Hampton, NJ

  • University of Alabama at Birmingham, Birmingham, AL

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Triple-negative breast cancer

  • Melanoma

  • Breast cancer

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • glembatumumab

  • CDX-011

Outcome

  • N/A

Study Design

  • N/A

Phase

  • II

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved